The term LOC645485 Inhibitors designates a specialized class of chemical compounds meticulously designed to modulate the activity of LOC645485, a molecular target currently under scientific investigation. These inhibitors are intricately crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of LOC645485 within cellular processes. The structural features of LOC645485 Inhibitors undergo a rigorous optimization process, often involving computational modeling and structure-activity relationship studies, to refine their molecular configurations for precise binding to the target.
The significance of LOC645485 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC645485, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC645485 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC645485 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC645485 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC645485 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
Intercalating agents can insert between DNA bases, potentially inhibiting transcription and affecting gene expression, including that of LOC645485. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $76.00 $143.00 $469.00 $775.00 | 18 | |
Alkylating agents can modify DNA bases, leading to DNA damage and potentially impeding transcription of various genes such as LOC645485. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
Glucocorticoids can affect gene expression by acting as transcription factors, which might lead to downregulation of LOC645485. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoids, through their interaction with retinoic acid receptors, can modulate gene expression, potentially affecting LOC645485. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, leading to reduced nucleotide synthesis and potentially downregulating gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA polymerase and thereby reducing transcription of genes, including potentially LOC645485. | ||||||
FABP4 Inhibitor | 300657-03-8 | sc-202606 | 5 mg | $208.00 | 2 | |
Inhibitors of histone acetyltransferases can alter chromatin structure and gene expression, which could include LOC645485. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $26.00 $34.00 | 20 | |
Aminoglycosides can bind to ribosomal RNA and cause mRNA mistranslation, which might indirectly inhibit expression of LOC645485. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $62.00 $92.00 $265.00 $409.00 $622.00 | 6 | |
Tetracyclines can inhibit protein synthesis by preventing tRNA attachment, leading to a downregulation of protein expression. | ||||||